MentalHealthDaily

Physical Activity Linked to Better Quality of Life in Teens

by GLOOM

MHD card showing a glowing teen runner on a curved school running track at night with a thought bubble that turns a jagged stress scribble into calm arcs, illustrating a survey linking physical activity to better quality of life in teens.

In a 2026 survey of 420 middle school students in eastern China, more physically active teens reported more cognitive reappraisal (reframing stressful situations), better stress-management habits and better health-related quality of life.1 Research Highlights Activity linked to quality of life through coping scores: the researchers’ model combined proposed links through reframing stressful situations and stress-management …

Parcel-Guided rTMS for Treatment-Resistant Depression: 6 of 11 Remitted in Pilot

by GLOOM

MHD card showing a dark violet mosaic of irregular brain-atlas parcels, with three highlighted parcels meeting at a glowing crosshair target beneath a figure-eight TMS coil, illustrating parcel-guided rTMS for treatment-resistant depression.

Researchers aimed repetitive transcranial magnetic stimulation (rTMS), which uses magnetic pulses to stimulate brain cells, at a spot chosen from each person’s own brain scan. In a small Columbia University pilot, 6 of 11 adults with treatment-resistant depression ended with low depression scores that met the trial’s remission threshold.1 Research Highlights Symptoms improved at the …

Anxiety and Depression in COPD: 18% Diagnosed, Most Treated With Benzodiazepines

by GLOOM

MHD card showing glowing outlined lungs with a branching cyan bronchial tree and flowing breath-wave lines, illustrating a Lithuanian study in which 18% of people with COPD had a recorded anxiety or depression diagnosis.

Nearly 1 in 5 people with COPD in Lithuania had a recorded diagnosis of anxiety or depression, according to a nationwide study of 64,246 patients. Anxiety was far more common than depression, and most patients who received medication were prescribed benzodiazepines.1 Research Highlights 18.1% had a recorded diagnosis: 11,608 of 64,246 adults with COPD in …

AI Chatbot Beat Group Therapy for Anxiety in 977 Students

by GLOOM

MHD card with a phone chat screen beside a circle of empty chairs: in 977 students, anxiety eased only with an AI chatbot, not group therapy; lonely users chatted most.

University students who used an AI chatbot for 12 weeks ended with anxiety scores about 2 points lower than students in weekly group therapy, in a randomized trial of 977 students in Israel.1 The gap was still there 3 months later. But it came less from the chatbot users improving a lot than from anxiety …

Suicide Attempts in Juvenile Justice: 45% Denied Suicidal Thoughts

by GLOOM

MHD card with 2 abstract intensity lines, one rising slowly and one flat then surging sharply in red, beside a grid of 20 dots with 9 lit in violet, showing that 45% of 1,250 youth in juvenile justice with a past suicide attempt denied suicidal thoughts.

A 2026 study of 1,250 Florida youth in juvenile-justice programs who had attempted suicide found that 557 (45%) denied serious suicidal thoughts or a plan. Anger or irritability was more common among them than among youth reporting suicidal thoughts (40% vs. 30%).1 An earlier 427-youth sample found a 40% denial rate.2 Screening that starts with …

Celecoxib for Depression: 7 Trials, Add-On Benefit Unclear

by GLOOM

MHD editorial card about celecoxib as an antidepressant add-on, showing a violet brain emblem, category tag, and three plain-language study takeaways.

A 7-trial review favored adding celecoxib to antidepressants for depression, but its benefit was not confirmed after 3 high-risk trials were excluded.

Antidepressants Did Not Shift Facial Emotion Recognition in Depression

by GLOOM

MHD featured image for antidepressant maintenance and facial emotion recognition in recurrent depression.

A 2026 ANTLER mechanistic analysis found no evidence that maintaining antidepressants preserved a happier facial-emotion recognition pattern compared with placebo substitution at 12 weeks (adjusted mean difference 0.23, 95% CI −0.5 to 1.0, p = 0.5) or 52 weeks (0.29, 95% CI −0.5 to 1.2, p = 0.5). Research Highlights No 12-week maintenance advantage: discontinuation …